UroToday13d
SCS AUA 2024: Urothelial Carcinoma of the Prostate and Intravesical Therapy: A Cautionary Tale
This study included a review of consecutive patients diagnosed with NMIBC between January 2005 and May 2023 to identify ...
Targeted Oncology2d
Mapping ctDNA Shedding Differences in GU Cancers With MRD Testing
Arnab Basu, MD, MPH, FACP, explains why sensitivity might be higher in urothelial cancer vs other genitourinary cancers.
Full House Star Dave Coulier Shares Stage 3 Cancer Diagnosis
Full House actor Dave Coulier is opening up about being diagnosed with stage 3 Non-Hodgkin's lymphoma: "It's a very ...
E!1d
Dave Coulier Says He's "OK If This Is the End" Amid Stage 3 Non-Hodgkin’s Lymphoma Battle
Full House alum Dave Coulier shared how his recent stage 3 Non-Hodgkin’s lymphoma diagnosis has affected his outlook on life.
Thousands of Georgians are diagnosed with lung cancer each year, and you don’t have to be a smoker
A 41-year-old Dunwoody mom who never smoked a day in her life was diagnosed with terminal stage 4 lung cancer.
Medindia7d
Carisma Unveils Promising Pre-Clinical Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma
"This novel off-the-shelf approach offers a promising new strategy for treating hepatocellular carcinoma, and we are eager to advance ... Inhibition in Murine Models of Breast, Colorectal, and ...
Pancreatic Ductal Adenocarcinoma Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers
DelveInsight’s Pancreatic Ductal Adenocarcinoma pipeline report depicts a robust space with 80+ active players working to ...
ImCheck to Present Updated Data from the EVICTION Trial at the 39th Annual Meeting of the Society for Immunotherapy of Cancer
ImCheck to Present Updated Data from the EVICTION Trial at the 39th Annual Meeting of the Society for Immunotherapy of CancerMarseille, France, ...
New research unveils mechanism behind deadly neuroendocrine prostate cancer
A leading scientist whose discoveries about prostate cancer led to lifesaving treatments is now shedding light on an emerging and deadlier form of the disease: neuroendocrine prostate cancer (NEPC).
Can-Fite Achieves Milestone with First Patient Dosing in Pancreatic Cancer Phase IIa Clinical Trial
Orphan Drug Designation has been granted lately by US FDARAMAT GAN, Israel, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE ...
Medindia7d
FDA Advisory Panel Votes in Favor of IceCure's ProSense® Cryoablation Benefit-Risk Profile in Early-Stage Low Risk Breast Cancer
Myeloid Therapeutics Announces SITC 2024 Oral Presentation on MT-303, the First in vivo GPC3 Targeting mRNA CAR in Human Studies for Advanced Hepatocellular Carcinoma (HCC ... Colorectal, and Prostate ...